MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition

por Vande Walle, Lieselotte, Stowe, Irma B., Šácha, Pavel, Lee, Bettina L., Demon, Dieter, Fossoul, Amelie, Van Hauwermeiren, Filip, Saavedra, Pedro H. V., Šimon, Petr, Šubrt, Vladimír, Kostka, Libor, Stivala, Craig E., Pham, Victoria C., Staben, Steven T., Yamazoe, Sayumi, Konvalinka, Jan, Kayagaki, Nobuhiko, Lamkanfi, Mohamed
Publicado 2019